LLY

988.33

+0.72%↑

JNJ

240.32

+0.33%↑

ABBV

229.95

-0.9%↓

NVS

159.76

-0.49%↓

AZN

194.37

-1.51%↓

LLY

988.33

+0.72%↑

JNJ

240.32

+0.33%↑

ABBV

229.95

-0.9%↓

NVS

159.76

-0.49%↓

AZN

194.37

-1.51%↓

LLY

988.33

+0.72%↑

JNJ

240.32

+0.33%↑

ABBV

229.95

-0.9%↓

NVS

159.76

-0.49%↓

AZN

194.37

-1.51%↓

LLY

988.33

+0.72%↑

JNJ

240.32

+0.33%↑

ABBV

229.95

-0.9%↓

NVS

159.76

-0.49%↓

AZN

194.37

-1.51%↓

LLY

988.33

+0.72%↑

JNJ

240.32

+0.33%↑

ABBV

229.95

-0.9%↓

NVS

159.76

-0.49%↓

AZN

194.37

-1.51%↓

Home・Akcijų sąrašas・Harmony Biosciences Holdings Inc

Harmony Biosciences Holdings Inc

Uždarymo kaina

SektoriusSveikatos priežiūra

28.13 -0.53

Pirkti Parduoti

Apžvalga

Akcijų kainos pasikeitimas

24 val.

Dabar

Min

27.55

Max

28.41

Pagrindiniai rodikliai
By Trading Economics
Pajamos	-187M -136M
Pardavimai	4.3M 244M
P/E Sektoriaus vid.	9.117 66.845
Pelnas, tenkantis vienai akcijai	1.08
Pelno marža	-55.871
Darbuotojai	293
EBITDA	-22M 52M

Rekomendacijos
By TipRanks
Rekomendacijos	Pirkti
12 mėnesių prognozė	+44.53% upside

Dividendai
By Dow Jones
Kitas uždarbis	2026-05-05

Rinkos statistika
By TradingEconomics
Rinkos kapitalizacija	117M 1.7B
Ankstesnė atidarymo kaina	28.66
Ankstesnė uždarymo kaina	28.13

Naujienos nuotaikos

By Acuity

38%

62%

123 / 351 reitingas Healthcare

Techninis įvertinimas

By Trading Central

Pasitikėjimas

Weak Bullish Evidence

29.8 / N/A Palaikymas ir pasipriešinimas

Harmony Biosciences Holdings Inc Grafikas

Ankstesni rezultatai nėra patikimas būsimų rezultatų rodiklis.

Susijusios naujienos

2026-03-05 23:01; UTC

Uždarbis

Costco Evaluating Possibility of Tariff Refunds as 2Q Revenue Rises - Update

2026-03-05 21:54; UTC

Uždarbis

Costco Posts Higher 2Q Profit on Rising Sales, Membership Fees

2026-03-05 21:35; UTC

Pagrindinės rinkos jėgos

ServiceNow Shares Rise After CEO Says AI Can Add Value to Software

2026-03-06 00:00; UTC

Svarbiausios naujienos

Its Missile Threat Degraded, Iran Is Taking Fewer Shots at More Targets -- WSJ

2026-03-05 23:46; UTC

Rinkos pokalbiai

Nikkei May Decline Amid Concerns About Energy Costs -- Market Talk

2026-03-05 23:33; UTC

Rinkos pokalbiai

Gold Edges Higher on Possible Technical Recovery -- Market Talk

2026-03-05 23:27; UTC

Rinkos pokalbiai

Middle East Fighting Will Prompt RBA to Delay Hike -- Market Talk

2026-03-05 22:54; UTC

Rinkos pokalbiai

Uždarbis

Costco Sold a $150,000 Diamond Ring in 2Q -- Market Talk

2026-03-05 22:50; UTC

Rinkos pokalbiai

Woodside Has More Exposure to Rising Gas Prices Than Santos -- Market Talk

2026-03-05 22:48; UTC

Uždarbis

Nike Reports $300 Million Pretax Charge Related to Job Cuts -- Barrons.com

2026-03-05 22:46; UTC

Uždarbis

Costco Evaluating Possibility of Tariff Refunds as 2Q Revenue Rises -- Update

2026-03-05 22:44; UTC

Uždarbis

Costco Earnings Beat Expectations as Membership Model Shines -- Barrons.com

2026-03-05 21:50; UTC

Rinkos pokalbiai

Tech, Media & Telecom Roundup: Market Talk

2026-03-05 21:50; UTC

Rinkos pokalbiai

Financial Services Roundup: Market Talk

2026-03-05 21:50; UTC

Rinkos pokalbiai

Health Care Roundup: Market Talk

2026-03-05 21:35; UTC

Uždarbis

Marvell Earnings Beat Estimates on 'Robust' AI Demand. The Stock Jumps. -- Barrons.com

2026-03-05 21:32; UTC

Uždarbis

Costco Earnings Beat Expectations as Membership Model Shines -- Barrons.com

2026-03-05 21:26; UTC

Uždarbis

These Stocks Are Today's Movers: Broadcom, Trade Desk, Berkshire Hathaway, Rigetti, Corning, Ciena, Expedia, and More -- Barrons.com

2026-03-05 21:24; UTC

Uždarbis

Costco February Digitally-Enabled Sales Ex-Changes in Gas and Foreign Exchange Rose 20.8% >COST

2026-03-05 21:23; UTC

Uždarbis

Costco February Same-Store Sales Ex-Changes in Gas and Foreign Exchange Rose 7% >COST

2026-03-05 21:22; UTC

Uždarbis

Costco 2Q Same-Store Sales Ex-Changes in Gas and Foreign Rose 6.7% >COST

2026-03-05 21:21; UTC

Uždarbis

Costco February Digitally-Enabled Sales Rose 21.8% >COST

2026-03-05 21:21; UTC

Uždarbis

Costco Total Co Comparable Sales for February Rose 7.9% >COST

2026-03-05 21:20; UTC

Uždarbis

Costco February Net Sales Were $21.69 B >COST

2026-03-05 21:20; UTC

Uždarbis

Marvell Earnings Beat Estimates on 'Robust' AI Demand. The Stock Jumps. -- Barrons.com

2026-03-05 21:20; UTC

Uždarbis

Costco Same-Store Sales Ex-Changes in Gas and Foreign Rose 6.7% >COST

2026-03-05 21:19; UTC

Uždarbis

Costco 2Q Digitally-Enabled Sales Ex-Changes in Gas and Foreign Exchange Rose 21.7% >COST

2026-03-05 21:18; UTC

Uždarbis

Costco 2Q Digitally-Enabled Sales Rose 22.6% >COST

2026-03-05 21:18; UTC

Uždarbis

Costco 2Q Same-Store Sales Up 7.4% >COST

2026-03-05 21:15; UTC

Uždarbis

Costco 2Q EPS $4.58 >COST

Akcijų palyginimas

Kainos pokytis

Harmony Biosciences Holdings Inc Prognozė

Kainos tikslas

By TipRanks

44.53% į viršų

12 mėnesių prognozė

Vidutinis 41.25 USD 44.53%

Aukščiausias 62 USD

Žemiausias 25 USD

Remiantis 8 „Wall Street“ analitikais, siūlančiais 12 mėnesių tikslines Harmony Biosciences Holdings Inc kainas – Dist per pastaruosius 3 mėnesius.

Bendras įvertinimas

By TipRanks

Pirkti

8 ratings

Pirkti

Laikyti

Parduoti

Remiantis 8 analitikų, pateikusių Harmony Biosciences Holdings Inc akcijų reitingus – Dist per pastaruosius 3 mėnesius.

Techninis įvertinimas

By Trading Central

29.8 / N/APalaikymas ir pasipriešinimas

Bullish events outweigh bearish events.

Recent bullish events outweigh bearish events.

All events are bearish.

Rinkos nuotaikos

By Acuity

123 / 351 reitingas Sveikatos priežiūra

Finansinės naujienos

Pardavimo ir administravimo išlaidos

Veiklos sąnaudos

Ikimokestinis pelnas

Pardavimai

Pardavimo savikaina

Bendrasis pelnas iš pardavimo

Skolų palūkanų išlaidos

EBITDA

Veiklos pelnas

Apie bendrovę Harmony Biosciences Holdings Inc

Harmony Biosciences Holdings, Inc., a commercial-stage pharmaceutical company, focuses on developing and commercializing therapies for patients with rare and other neurological diseases in the United States. The company offers WAKIX (pitolisant), a molecule with a novel mechanism of action for the treatment of excessive daytime sleepiness in adult patients with narcolepsy. It also offers HBS-102, a melanin-concentrating hormone receptor 1 for MCH neurons. The company was formerly known as Harmony Biosciences II, Inc. and changed its name to Harmony Biosciences Holdings, Inc. in February 2020. Harmony Biosciences Holdings, Inc. was incorporated in 2017 and is headquartered in Plymouth Meeting, Pennsylvania.